Physician profile
Oghale E Eleyae
NPI 1811148539
$11,905.76
in general payments reported to CMS, 2019-2025
13 companies · $4,851 in 2025
The $4,851 reported for 2025 was more than what 96% of Podiatrist providers received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,233 · 2020: $58.76 · 2021: $1,510 · 2022: $261 · 2023: $295 · 2024: $3,697 · 2025: $4,851.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Debt Forgiveness: $4,800 · Travel and Lodging: $2,811 · Food and Beverage: $1,232.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Debt Forgiveness | $4,800.00 |
| Travel and Lodging | $2,811.43 |
| Food and Beverage | $1,231.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Convatec INC. | $4,918.06 | 2023-2025 | |
| Stryker Corporation | $4,232.93 | 2021-2024 | Hoffmann, Prostep, Inbone |
| Wright Medical Technology, INC. | $1,156.82 | 2019 | |
| Organogenesis INC. | $615.80 | 2020-2023 | Puraply |
| Kerecis Limited | $384.33 | 2021-2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Paratek Pharmaceuticals, INC. | $367.92 | 2021-2024 | Nuzyra |
| Abbvie INC. | $65.80 | 2022-2023 | |
| Integra Lifesciences Corporation | $43.63 | 2019-2023 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $35.46 | 2025 | Caplyta |
| Tei Medical INC. | $29.61 | 2019 | |
| Treace Medical Concepts, INC. | $23.46 | 2022 | |
| Merck Sharp & Dohme LLC | $16.37 | 2019 | |
| Insulet Corporation | $15.57 | 2025 | Omnipod |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Oghale Eleyae listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.